FUSN - Fusion Pharmaceuticals  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $22.48. This is a potential upside of $0.93 (4.32%) from yesterday's end of day stock price of $21.55.

Fusion Pharmaceuticals 's activity chart (see below) currently has 12 price targets and 11 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 55.95% with an average time for these price targets to be met of 301.14 days.

Most recent stock forecast was given by GREGORY RENZA from RBC on 20-Mar-2024. First documented stock forecast 21-Jul-2020.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$16

$-5.55 (-25.75%)

$16

1 years 6 months 14 days ago
(20-Mar-2024)

1/2 (50%)

$-5.09 (-24.13%)

15

Hold

$13

$-8.55 (-39.68%)

$13

1 years 6 months 14 days ago
(20-Mar-2024)

3/4 (75%)

$-8.09 (-38.36%)

287

Hold

$11

$-10.55 (-48.96%)

$10

1 years 6 months 15 days ago
(19-Mar-2024)

1/2 (50%)

$-10.18 (-48.06%)

496

Buy

$13

$-8.55 (-39.68%)

$13

1 years 8 months 8 days ago
(26-Jan-2024)

2/3 (66.67%)

$2.11 (19.38%)

131

Buy

$16

$-5.55 (-25.75%)

$15

1 years 8 months 29 days ago
(05-Jan-2024)

4/4 (100%)

$7.65 (91.62%)

143

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FUSN (Fusion Pharmaceuticals ) average time for price targets to be met?

On average it took 301.14 days on average for the stock forecasts to be realized with a an average price target met ratio 55.95

Which analyst has the current highest performing score on FUSN (Fusion Pharmaceuticals ) with a proven track record?

YUAN ZHI

Which analyst has the current lower performing score on FUSN (Fusion Pharmaceuticals ) with a proven track record?

GREGORY RENZA

Which analyst has the most public recommendations on FUSN (Fusion Pharmaceuticals )?

Yuan Zhi works at B. RILEY and has 3 price targets and 2 ratings on FUSN

Which analyst is the currently most bullish on FUSN (Fusion Pharmaceuticals )?

John Walsh with highest potential upside - $0

Which analyst is the currently most reserved on FUSN (Fusion Pharmaceuticals )?

Nicole Germino with lowest potential downside - -$10.55

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?